TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03808883 |
|
Recruitment Status : Unknown
Verified January 2019 by Misty Luminais, Case Western Reserve University.
Recruitment status was: Not yet recruiting
First Posted : January 18, 2019
Last Update Posted : January 18, 2019
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gender Identity | Behavioral: TGNC Directed Advocacy Meetings | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 50 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | All participants will be assigned to the intervention |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Understanding and Reducing Health Disparities Faced by Transgender and Gender Non-conforming (TGNC) Individuals in Cleveland Through TGNC-Directed Advocacy |
| Estimated Study Start Date : | February 2019 |
| Estimated Primary Completion Date : | November 2019 |
| Estimated Study Completion Date : | January 2020 |
- Behavioral: TGNC Directed Advocacy Meetings
Series of community meetings with TGNC individuals to include meeting with health professionals to articulate barriers to access and to enter into dialogue with medical providers and staff
- Change in knowledge of TGNC individuals of total number of locations to receive medical care in Cleveland known [ Time Frame: 9 months - 1 year ]Pre/post test free list of all places medical care can be accessed - change measured in total number of answers given
- Change in knowledge of medical providers of total number of medical and social issues faced by TGNC individuals [ Time Frame: 3 months - 6 months ]Pre/post test free list of all issues TGNC individuals face - change measured in total number of answers given
- Change in attitude of TGNC individuals towards healthcare providers' sensitivity to transgender issues as measured by 10 Likert scale questions developed for this project [ Time Frame: 9 months - 1 year ]pre/post test survey of 10 Likert scale measures on a scale of 1-5
- Change in attitude of medical providers towards transgender issues as measured by 10 Likert scale questions developed for this project [ Time Frame: 3 months - 6 months ]pre/post test survey of 10 Likert scale measures on a scale of 1-5
- Qualitative shift in confidence of TGNC individuals in seeking medical care after the intervention based on semi-structured interviews created for this project [ Time Frame: 1 year ]post-intervention semi-structured interview conducted by trained anthropologist with tool developed for this project and analyzed with qualitative data analysis software for emergent themes and repetition of a priori codes
- Qualitative shift in confidence of medical provider in providing culturally competent medical care to TGNC individuals after the intervention based on semi-structured interviews created for this project [ Time Frame: 6 months ]post-intervention semi-structured interview conducted by trained anthropologist with tool developed for this project and analyzed with qualitative data analysis software for emergent themes and repetition of a priori codes
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 14 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | TGNC cohort must self-identify as transgender or gender nonconforming |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- self-identify as transgender or gender nonconforming
- fluent English speaker
- above the age of 14 years old
Exclusion Criteria:
- non-fluent English speaker
- below the age of 14 years old
- does not identify as transgender or gender nonconforming
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03808883
| Contact: Misty Luminais, PhD | 216-368-1329 | misty.luminais@case.edu | |
| Contact: Wendy Boerger | 216-368-5235 | wendy.boerger@case.edu |
| Responsible Party: | Misty Luminais, Senior Research Associate, Case Western Reserve University |
| ClinicalTrials.gov Identifier: | NCT03808883 |
| Other Study ID Numbers: |
IRB-2018-2194 |
| First Posted: | January 18, 2019 Key Record Dates |
| Last Update Posted: | January 18, 2019 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Barriers to Healthcare Access Participatory Action Research Cultural Competency |

